Increasingly, consumers have been able to seek DNA testing online to explore their personal genetic information. This increased access to a range of genomic tests has raised concerns among health professionals tasked with providing guidance and support to patients requiring genetic/genomic testing. Individuals will seek genomic testing for a range of purposes; equally, the medical marketplace offers a range of different test types. The Human Genetics Society of Australasia (HGSA) published their first statement on Direct to Consumer Genetic Testing (2012 PS02). This is a revised statement, which considers developments in the field of online DNA testing, including rapid technological changes, diversity of applications and decreasing costs of testing. It draws from the first empirical nationwide study (Genioz – Genomics: National Insights of Australians) and insights from consumers with experience of this technology. The rapid adoption of these tests and the broad range of potential consequences have informed perspectives within this statement. It is the position of the HGSA that both individuals/consumers and health care professionals/providers should be supported to make informed choices about online DNA testing. This means adequate and ongoing education and resources should be available for individuals/consumers and health care professionals/providers before, during and after testing. Health care professionals/providers should be appropriately trained, have relevant experience and should be able to demonstrate (or provide evidence of) a current certification in their field of practice. This statement was ratified at the 2018 HGSA Council Meeting and was recently reviewed in 2019 for consistency with other HGSA position statements.

中文翻译：

---

大洋洲人类遗传学会立场声明：在线 DNA 检测

越来越多的消费者能够在线寻求 DNA 测试以探索他们的个人遗传信息。这种增加获得一系列基因组测试的机会引起了卫生专业人员的关注，他们的任务是为需要基因/基因组测试的患者提供指导和支持。个人将出于多种目的寻求基因组测试；同样，医疗市场提供一系列不同的测试类型。澳大利亚人类遗传学会 (HGSA) 发表了他们关于直接面向消费者的基因检测的第一份声明 (2012 PS02)。这是一份修订后的声明，考虑了在线 DNA 检测领域的发展，包括快速的技术变革、应用的多样性和检测成本的降低。它来自第一个全国性实证研究（Genioz – Genomics：National Insights of Australians) 以及具有该技术经验的消费者的见解。这些测试的迅速采用和广泛的潜在后果在本声明中提供了丰富的观点。HGSA 的立场是，个人/消费者和医疗保健专业人员/提供者都应该得到支持知情选择关于在线 DNA 检测。这意味着应提供充分和持续的教育和资源适用于测试之前、期间和之后的个人/消费者和医疗保健专业人员/提供者。卫生保健专业人员/提供者应经过适当培训，具有相关经验，并应能够证明（或提供证据）其实践领域的当前认证。该声明在 2018 年 HGSA 理事会会议上获得批准，最近在 2019 年进行了审查，以与其他 HGSA 立场声明保持一致。